Hot Long Term Companies To Buy For 2015

Cheap stocks: They give you more for your money, but they're just as much a mixed bag of strong and poor companies as pricey picks. The price-to-earnings ratio has long been used to judge the general price of a stock, but is this polarizing statistic a good way to value big pharma's ostensibly cheapest stocks?

Using data compiled by stock screening site Finviz, here are the three cheapest major pharmaceutical stocks sorted by P/E. Motley Fool contributor Dan Carroll tells you what you need to know about these picks -- and whether their businesses and outlooks really are worth your money.

While you can certainly make huge gains in biotech and pharmaceuticals, the best investing approach is to choose great companies and stick with them for the long term. The Motley Fool's free report "3 Stocks That Will Help You Retire Rich" names stocks that could help you build long-term wealth and retire well, along with some winning wealth-building strategies that every investor should be aware of.�Click here now�to keep reading.

Hot Long Term Companies To Buy For 2015: Abu Dhabi Islamic Bank Egypt SAE (ADIB)

Abu Dhabi Islamic Bank Egypt SAE, formerly National Bank for Development (NBD), is an Egypt-based public shareholding company engaged in the provision of retail, corporate and investment banking services through a network of 69 branches located across Egypt. The Bank�� products and services are structured into four segments: the Personal banking segment includes current and saving account, investment account, club finance, charitable accounts and sukuk, among others; the Microfinance segment includes microfinance program; the Wholesale banking segment includes corporate banking, financial institutions and trade, cash management and corporate finance, and the Treasury segment includes foreign exchange, sharia-compliant products and market analysis/updates. In January 2014, the Company sold 11,619,575 shares representing 77.46% stake in National Company for Glass and Crystal�� share capital to Abu Dhabi Islamic Financial Investments Holding. Advisors' Opinion:

• [By Gregor Stuart Hunter]

  Tirad Mahmoud, the chief executive of Abu Dhabi Islamic Bank (ADIB), has warned of "irrational exuberance" in the UAE's corporate lending market, saying companies are seeking to lower borrowing costs by so much that banks may no longer find it appealing to lend.

Hot Long Term Companies To Buy For 2015: Salix Pharmaceuticals Ltd (SLXP)

Salix Pharmaceuticals, Ltd., incorporated on December 31, 2001, is a specialty pharmaceutical company dedicated to acquiring, developing and commercializing prescription drugs and medical devices used in the treatment of a variety of gastrointestinal disorders, which are those affecting the digestive tract. As of December 31, 2012, the Company�� products included XIFAXAN, MOVIPREP, APRISO, RELISTOR, OSMOPREP, SOLESTA, DEFLUX, FULYZAQ, GIAZO, METOZOLV ODT, AZASAN, ANUSOL-HC, PROCTOCORT, PEPCID, DIURIL and COLAZAL. As of December 31, 2012, its primary product candidates under development included Rifaximin, Methylnaltrexone bromide oral, Budesonide foam and Rifaximin EIR. In January 2014, Salix Pharmaceuticals, Ltd. acquired Santarus, Inc.

Xifaxan (rifaximin) tablets

Xifaxan is a gastrointestinal-specific oral antibiotic. The Food and Drug Administration ( FDA) approved Xifaxan 200 milligram for the treatment of patients 12 years of age and older with travelers��diarrhea caused by noninvasive strains of E coli. Xifaxan 550 milligram was approved by the FDA for reduction in risk of overt hepatic encephalopathy (HE), recurrence in patients 18 years of age or older.

It launched Xifaxan 200milligram in the United States and Xifaxan 550 milligram using its own direct sales force. The Company is exploring potential additional indications, formulations, clinical trials and co-promotion arrangements to capitalize on the potential for Xifaxan, including its development program in irritable bowel syndrome.

In October 2012, the USPTO declared an interference action to determine the priority of invention between Cipla�� application related to amorphous rifaximin and Solmag SpA�� application directed to amorphous rifaximin. In February 2012, the FDA posted draft bioequivalence guidance for rifaximin 550 milligram tablets. The draft guidance for rifaximin 550 milligram tablets recommends that in addition to conducting the program outlined in the FDA posted ! draft guidance document for rifaximin 200 milligram tablets discussed above, a single-dose, three-way crossover in-vivo study of fasting bioequivalence with pharmacokinetic endpoints in both fasting and fed states be performed in the 550 milligram tablets. Additionally, the guidance stipulated that the formulation of the 550 milligram strength should be proportionally similar to that of the 200 milligram strength in order to file an ANDA for approval of a generic rifaximin 550 milligram tablet for the treatment of hepatic encephalopathy.

MoviPrep (PEG 3350, sodium sulfate, sodium chloride, potassium chloride, sodium ascorbate and ascorbic acid) oral solution

MoviPrep is a patent-protected, liquid polyethylene glycol-salt, or PEG, bowel cleansing product that the FDA approved. MoviPrep is indicated for bowel cleansing prior to colonoscopy, intestinal surgery and barium enema X-ray examinations.

Apriso (mesalamine) extended-release capsules 0.375 gram

Apriso is a locally-acting aminosalicylate and is the only delayed and extended release mesalamine product approved by the FDA for once-a-day dosing for the maintenance of remission of ulcerative colitis. Apriso is designed to provide for the distribution of the active ingredient beginning in the small bowel and continuing throughout the colon. The product�� prolonged release mechanism might allow them to expand the range of treatment options for ulcerative colitis.

Relistor (methylnaltrexone bromide)

Relistor Subcutaneous Injection is indicated for the treatment of opioid-induced constipation (OIC) in patients with advanced illness who are receiving palliative care, when response to laxative therapy has not been sufficient. Relistor is approved for use in over 55 countries worldwide.

OsmoPrep and Visicol (sodium phosphate monobasic monohydrate, USP, sodium phosphate dibasic anhydrous, USP) tablets

Visicol and OsmoPrep tablets are indicated for clean! sing of t! he colon as a preparation for colonoscopy in adults 18 years of age or older. Visicol and OsmoPrep are the only, tablet bowel cleansing products approved by the FDA and marketed in the United States. OsmoPrep is a patented, second-generation tablet bowel cleansing product that the FDA approved. OsmoPrep offers potential benefits compared to Visico,l such as its lack of microcrystalline cellulose, smaller tablet size and possible lower dose administration.

Solesta

Solesta is a biocompatible tissue bulking agent, consisting of dextranomer microspheres and stabilized sodium hyaluronate. Solesta is indicated for the treatment of fecal incontinence in patients 18 years and older who have failed conservative therapy, such as diet, fiber therapy and/or anti-motility medications. It is the only injectable gel for this indication to be administered in an outpatient setting without the need for surgery or anesthesia.

Deflux

Deflux is a medical device indicated for children affected by Grades II-IV vesicoureteral reflux, a malformation of the urinary bladder that can result in severe infections of the kidneys and irreversible kidney damage. Deflux was granted premarket approval application (PMA) approval, and has been on the market in the United States.

Fulyzaq (crofelemer) delayed-release tablets

On December 31, 2012, the FDA granted marketing approval for this product, under the trade name Fulyzaq. Fulyzaq is indicated for the symptomatic relief of non-infectious diarrhea in adult patients with HIV/AIDS on anti-retroviral therapy. Fulyzaq should also be eligible for five years of marketing exclusivity from the date of FDA approval, and the product might be entitled to patent term restoration.

Giazo (balsalazide disodium) tablets

February 3, 2012, the FDA granted marketing approval for this product under the trade name Giazo. Giazo is indicated for the treatment of mildly to moderately active ulcerative col! itis in m! ale patients 18 years of age and older. It shipped Giazo to wholesalers in 2012.

Metozolv ODT (metoclopramide hydrochloride) 5 milligrams and 10 milligrams orally disintegrating tablets

METOZOLV ODT is indicated for the relief of symptomatic gastroesophageal reflux or short-term (4-12 weeks) therapy for adults with symptomatic, documented gastroesophageal reflux who fail to respond to conventional therapy and diabetic gastroparesis or the relief of symptoms in adults associated with acute and recurrent diabetic gastroparesis.

Azasan (azathioprine) tablets

Azasan is an FDA-approved drug that suppresses immune system responses and is indicated for preventing rejection of kidney transplants and treatment of severe arthritis. It launched the 75 and 100 milligrams dosage strengths of Azasan in the United States.

Anusol-HC and Proctocort (hydrocortisone) creams and suppositories

The Company acquired the right to sell Anusol-HC 2.5% (hydrocortisone USP) cream, Anusol-HC 25 milligrams (hydrocortisone acetate) rectal suppositories, Proctocort 1% (hydrocortisone USP) cream and Proctocort 30 mg (hydrocortisone acetate) rectal suppositories from King Pharmaceuticals, Inc. The two cream products are topical corticosteroids indicated for relief of the inflammatory and pruritic, or itching, manifestations of corticosteroid-responsive dermatoses. The two suppository products are indicated for use in inflamed hemorrhoids and postirradiation proctitis, as well as an adjunct in the treatment of chronic ulcerative colitis and other inflammatory conditions.

Pepcid (famotidine) for Oral Suspension and Diuril (Chlorothiazide)

Pepcid Oral Suspension is a widely known prescription pharmaceutical product indicated for several gastrointestinal indications, including the treatment of duodenal ulcer, benign gastric ulcer and gastro-esophageal reflux disease. Pepcid Oral Suspension and Diuril Oral Suspension, both liquid form! ulations ! of their solid dosage form counterparts, compete in a combined annual United States market concentrated in pediatric and hospitalized patient populations.

Colazal (balsalazide disodium) capsules

The Company launched Colazal to physicians in the United States. FDA approved Colazal for use in pediatric patients between 5 to 17 years of age with ulcerative colitis. The pediatric use of Colazal has been granted orphan drug designation. The Office of Generic Drugs, or OGD, approved three generic balsalazide capsule products.

The Company competes with GlaxoSmithKline plc, Giuliani S.p.A., Axcan Pharma, Inc., Abbott Laboratories, Warner Chilcott plc, Shire Pharmaceuticals Group plc, Pharmacia & Upjohn, Inc., Alaven Pharmaceutical LLC, Ferring Pharmaceuticals, Inc, Takeda Pharmaceutical Company Limited, Cumberland Pharmaceuticals, Inc, Prometheus Laboratories, Inc., Ranbaxy Pharmaceuticals, Ferndale Laboratories, GATE Pharmaceuticals , Nycomed , Medtronic, Inc., and Cubist Pharmaceuticals, Inc.

Advisors' Opinion:

• [By Paul Ausick]

  Stocks on the Move: Twitter Inc. (NYSE: TWTR) is down 7.3% at $41.64 on its second day of trading and word is that some hedge funds and traders are looking to borrow shares. Santarus Inc. (NASDAQ: SNTS) is up 37.6% at $31.95 after agreeing late Thursday night to an acquisition by Salix Pharmaceuticals Inc. (NASDAQ: SLXP) for $2.6 billion in cash.

• [By Jake L'Ecuyer]

  Equities Trading UP
  Santarus (NASDAQ: SNTS) shot up 37.95 percent to $32.03 after Salix Pharmaceuticals (NASDAQ: SLXP) announced its plans to buy Santarus for around $2.12 billion. Santarus and Pharming also announced new data from open-label repeat treatment study with RUCONEST.

• [By David Williamson]

  In this segment, health-care analyst David Williamson takes a look at the upcoming acquisition by Salix Pharmaceuticals (NASDAQ: SLXP  ) of Santarus (NASDAQ: SNTS  ) for about $2.6 billion. Salix is currently a maker of drugs for gastrointestinal diseases, and the immediately accretive deal will give Salix access to treatments for both diabetes and heartburn. Shares of both companies were up significantly on the news. David tells investors why shareholders should be pleased with this deal on both ends and what he thinks of the stock going forward.

• [By Lisa Levin]

  Santarus (NASDAQ: SNTS) shares surged 37.64% to touch a new 52-week high of $31.96 after Salix Pharmaceuticals (NASDAQ: SLXP) announced its plans to buy Santarus for around $2.12 billion. Santarus and Pharming also announced new data from open-label repeat treatment study with RUCONEST.

Top Industrial Disributor Companies To Watch In Right Now: Single Touch Systems Inc (SITO.OB)

Single Touch Systems, Inc., incorporated on incorporated on May 31, 2000, is a mobile media solutions provider serving retailers, advertisers and brands. The Company offers its patented technologies through a modular, adaptable platform and a multi-channel messaging gateway to its customers, enabling them to reach consumers on all types of connected devices. Its solution is designed to drive return on investment for high-volume clients and/or customized branded advertisers. Its platform and tools are designed to enable brands or anyone with substantial reach to utilize the mobile device as a new means to communicate. Communication might be in the form of a reminder message in voice or Short Message Service (SMS), an abbreviated dial code or a coupon, promotion, or an advertisement. On July 26, 2013, the Company dismissed Weaver, Martin & Samyn, LLC (Weaver).

Messaging and Notifications

The Company�� Short Message Service (SMS) gateway has to be a channel for retailers to communicate with their brand loyalists on a personal level. This is accomplished through integration with the client�� customer relationship management (CRM) database. With such integration, retailers are able to send targeted mobile coupons and transactional messages based on a shopper�� CRM profile. Targeted mobile coupons can be sent based on past purchase behaviors making the content relevant and timely to a shopper. Transactional messages can add another layer of value by sending shipping and order pick-up alerts, as well as notifications for reorders, layaway and new product releases.

Abbreviated Dial Codes

The Company�� abbreviated dial codes have 10 times the recall of a common keyword-to-short-code solution. The Company has seen many of its clients using this as an on-ramp to mobility solutions.

Campaign Management and Analytics

The Company�� anywhere management platform is an easy to use Web interface that allows clients to manage and se! gment messaging campaigns with customized reporting tools. Its clients use this tool to drive campaigns related to in store events, product offerings, information and special sales. The message management systems enables the user to create a message, schedule its delivery time and frequency, segment audience groups for distribution and create message responders.

FollowMe

FollowMe provides a product to deliver location based mobile ads directly to consumers��smartphones for retailers and advertisers. The Company has found that by combining multiple real time bidding networks with its ability to serve coupons, ads and promotions at times and places when consumers are interested, it can create relevant content for consumers. FollowMe enables advertisers to deliver targeted ads in App to the smartphones of people within close proximity of a specific location. This service is offered by partnering with TheMobile Audience, a mobile demand side platform (DSP) that enables programmatic buying of mobile media across multiple real-time bidding (RTB) networks.

The Company compets with Voltari, Hippcricket and Hippcricket.

Advisors' Opinion:

• [By Markman Advisors]

  Public companies leveraging their patent portfolios, (aka "patent plays"), are getting the market's attention. Companies such as Vringo (VRNG), ParkerVision (PRKR), MGT Capital (MGT), Worlds Inc. (WDDD.OB) and others have presented trading opportunities due to their volatility while retaining the chance for a big payoff to those investors who stay the course. Yet there exist viable patent plays that are still undiscovered. Some of these so called "plays," which are not getting enough attention, are actually real companies making and selling real products or services in contrast to pure patent monetization companies. Some known examples are Single Touch Interactive (SITO.OB) and Blue Calypso (BCYP.OB). This article is focused on another one of these patent plays, On Track Innovations Ltd. (OTIV).

Hot Long Term Companies To Buy For 2015: Anhanguera Educacional Participacoes SA (AEDU3)

Anhanguera Educacional Participacoes SA, formerly Mehir Holdings SA, is a Brazil-based holding company engaged in the education sector. The Company provides higher graduate and postgraduate education through full time and distance learning programs. It is also engaged in the provision of preparatory courses for public competition and other specialization courses. The Company offers the academic programs, such as full time graduate, distance graduate and post-graduate courses. Additionally, the Company provides selected courses through the methodology of distance learning, including graduate, post-graduate and continuous education courses. Anhanguera Educacional Participacoes SA offers its services for working adults and operates in approximately 71 campuses and around 500 learning centers located throughout each of around the 26 Brazilian states. Advisors' Opinion:

• [By Ney Hayashi]

  Anhanguera Educacional Participacoes SA (AEDU3) tumbled after Brazil�� antitrust regulator signaled it may limit the education company�� merger with competitor Kroton Educacional SA. (KROT3) Lojas Renner SA (LREN3) led retailers higher after a report showed Brazil�� industrial production expanded faster than expected in October, easing concern that growth is faltering.

Hot Long Term Companies To Buy For 2015: Fenner PLC (FENR)

Fenner PLC is a manufacturer and distributor of reinforced polymer products. It operates in two segments: engineered conveyor solutions, which is engaged in the manufacture of rubber, polyvinyl chloride and steel cord conveyor belts, ply, solid woven and steel cord conveyor belting for mining, power generation and industrial applications and advanced engineered products, which is engaged in the manufacture of precision polymer products; problem-solving power transmission and motion transfer components; silicone and complex hoses for heavy duty trucks, buses and off-road vehicles; seals and sealing solutions for the fluid power and oil and gas industries; technical textiles for medical and industrial applications and silicone based products for medical applications; rollers for digital image processing and medical diagnostics, and fluropolymer components for fluid and gas handling. Advisors' Opinion:

• [By Inyoung Hwang]

  Fenner Plc (FENR) rallied 5.2 percent to 407.4 pence, its highest price since March 20. UBS AG started coverage of the conveyor-belt maker with a buy rating, saying shares are cheap. The bank predicted the stock will climb to 460 pence in the next 12 months.

Hot Long Term Companies To Buy For 2015: Tremor Video Inc (TRMR)

Tremor Video, Inc.( Tremor Video), incorporated on November 22, 2005, is a provider of technology-driven video advertising solutions enabling brand advertisers to engage consumers across multiple Internet-connected devices, including computers, smartphones, tablets and connected televisions. The Company�� clients include brand advertisers globally, including automakers and consumer packaged goods companies. The Company�� technology, VideoHub, analyzes in-stream video content, detects viewer and system attributes, and leverages its repository of stored data to optimize video ad campaigns for brand-centric metrics. VideoHub also provides advertisers and agencies with analytics and measurement tools enabling them to understand why, when and where viewers engage with their video ads.

VideoHub

VideoHub powers the Company�� video advertising solutions. Through VideoHub it delivers brand-centric key performance indicators, distinct signals to drive optimization, brand-centric optimization, in-stream video analysis and categorization, ad performance transparency, ad placement transparency, and cross site and channel measurement.

The Company has a range of brand-centric key performance indicators (KPIs), such as engagement (that is, the interaction of a viewer with a video ad), brand lift (that is, a positive shift in preference towards a brand or branded product driven by exposure to a video ad and brand education), and time spent (that is, the amount of time a viewer spends with a video ad), which are tailored to the needs of brand advertisers. Throughout a campaign VideoHub analyzes and stores data for all KPIs in its suite. Using a training algorithm, VideoHub trains a series of statistical predictive models to build a decision tree, which predicts performance of the video ad campaign for the chosen KPI.

VideoHub performs an analysis on every video stream and categorizes it among one of approximately 72 video content categories. It also has the ab! ility to scan and categorize content by analyzing the audio track and certain visual elements. VideoHub offers advertisers transparency into the workings of its decision tree. VideoHub tracks the number of impressions served to a specific publisher site and whether a video ad placement is fully, partially or not visible to a viewer, which it refer to as viewability.

The Company�� metric, eQ score+, allows advertisers to compare video inventory quality across different publisher sites by measuring attributes such as viewability, the size of the video player and ad completion rate. When coupled with pricing information, these insights help advertisers compare the relative value of video inventory across publishers.

Tremor Video Network

The Tremor Video Network offers advertisers access to video inventory at scale across multiple devices in brand safe environments. Through the Tremor Video Network it delivers scale and reach across multiple devices, premium video content, brand safety, in-stream video focus, advanced ad formats, and pricing models. The Tremor Video Network delivers scale and reach across multiple Internet-connected devices, including computers, smartphones, tablets and connected television, enabling its clients to use its solutions to address their online video advertising needs across these devices.

The Company�� technology scans and categorizes every video within the Tremor Video Network and prevents video ads from being served within content, which is identified as objectionable for the brand advertiser, including content which contains accidents, distasteful or obscene language, substance abuse, violence, gambling, sex or crime. It specializes in delivering in-stream video advertisements, which can be served to viewers prior to or during the publisher's content when they are the most engaged.

The Company�� ad formats include Super Pre-Roll, Pre-Roll Plus and Pre-Roll Extended Play. The Company offers brand perform! ance-base! d pricing models for in-stream video advertisements, which are tied to the effectiveness of the Tremor Video Network, as advertisers using these models pay the Company only if their video ad campaigns perform.

VideoHub for Advertisers (VHA)

The Company is licensing VHA, a software platform, which client access through a Web portal. By licensing VHA, advertisers and their agencies can use VHA across the entirety of their video ad buys, including on publisher sites. In order to analyze video ad campaigns running outside the Tremor Video Network, VideoHub generates a tracking code which is associated with the video ad unit that the advertiser or agency wishes to analyze through VHA. Advertisers and agencies can then access VideoHub's advanced analysis of this data through VHA in order to gain valuable insights into campaign performance, including the performance of the campaign on a particular publisher's site.

The Company competes with Hulu, LLC, Google Inc., BrightRoll, Inc., YuMe, Inc., CBS, CNN, ESPN, Adap.tv, Inc., Videology, Inc., Facebook, Inc., Microsoft Corporation, Yahoo! Inc. and Adobe Systems Incorporated.

Advisors' Opinion:

• [By John Udovich]

  Small cap video technology stocks Envivio Inc (NASDAQ: ENVI), Ku6 Media Co Ltd (NASDAQ: KUTV) and Tremor Video Inc (NYSE: TRMR) made some interesting moves today and in recent days or months���meaning its worth taking a closer look at all three to see if there might be opportunities for traders and investors alike:

• [By Rick Munarriz]

  Tremor Video (NYSE: TRMR  ) -- $7.97
  Tremor went public at $10 a share late last month, and it's already a busted IPO.

  The company seems to be at the right place at the right time. Tremor runs an online video advertising network at a time when everyone is gravitating to video content. Tremor's VideoHub platform analyzes in-stream video content to serve up optimal video ad campaigns. Its clients include all 10 of the largest automakers and all but one of the 10 largest packaged goods companies.

• [By Helix Investment Research]

  We note that Keating Capital's co-investors in many of its portfolio companies are not simply other venture capital or existing investors, but strategic investors as well. Examples include Agilyx, where Waste Management (WM) is a co-investor, BrightSource, where Chevron (CVX) and BP (BP) are co-investors, Kabam, where Google (GOOG) and Intel (INTC) are co-investors, or Tremor Video (TRMR), where Time Warner (TWX) is a co-investor. As of the end of Q2 2013, 9 (excluding Jumptap) of Keating Capital's portfolio companies had unrealized gains, with an average gain of 25.6% (again excluding Jumptap, which had unrealized gains of 8% as of the end of Q2 2013). The remaining 6 companies had an average loss of 44.46%. However, on an overall basis, Keating Capital's portfolio currently has an average unrealized gain of 2.15%. While this is not a large gain, we note that the bulk of Keating Capital's profits are realized upon exiting an investment in conjunction with the portfolio company's IPO or sale. Furthermore, portions of Keating Capital's portfolio are defended by structurally protected appreciation clauses that the company has struck with its portfolio companies, clauses that are not reflected on its balance sheet. These clauses, which are negotiated between Keating Capital and its portfolio companies, allow the company to receive shares in the portfolio company's IPO at a discount, or grant it warrants to purchase additional shares in an IPO for a nominal price. Since inception, Keating Capital has negotiated structurally protected appreciation clauses in 11 of the 20 companies it has invested in. As of the end of Q2 2013, 6 of Keating Capital's 15 portfolio companies were protected by structurally protected appreciation clauses, representing $22 million in total capital (almost 43% of the company's invested capital), thereby entitling Keating Capital to a weighted-average aggregate value of 1.9x its investment at the time of an IPO.

• [By John Udovich]

  Yesterday, small cap advertising solutions stock�Rocket Fuel Inc (NASDAQ: FUEL) jumped 13.55% while peer Tremor Video Inc (NYSE: TRMR) rose 8.24%. So what is going on with these two small caps and which one might be the better deal?

Hot Long Term Companies To Buy For 2015: ACADIA Pharmaceuticals Inc.(ACAD)

ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on drug discovery and clinical development of novel treatments for central nervous system disorders. The company has a portfolio of four product candidates, including pimavanserin, which is in Phase III clinical development as a treatment for Parkinson's disease psychosis. It is also developing AGN-XX/YY, a product candidate in Phase II for chronic pain; and AC-262271, a product candidate in Phase I for glaucoma in collaboration with Allergan, as well as AM-831, a product candidate in IND-track development in collaboration with Meiji Seika Kaisha, Ltd. In addition, ACADIA Pharmaceuticals Inc. is developing two preclinical programs in the area of Parkinson?s disease. The product candidates in the company?s pipeline emanate from discoveries made using its proprietary drug discovery platform. The company was founded in 1993 and is headquartered in San Diego, California.

Advisors' Opinion:

• [By Bryan Murphy]

  Call them hunches (because that's all they are), but now would be a great time to get out of a NanoTech Entertainment, Inc. (OTCMKTS:NTEK) position and/or get into an ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD). NTEK looks like its reached its maximum potential - for the time being - while ACAD looks like it's ready to start rolling higher again.

• [By Brian Orelli]

  There goes the short-term bear thesis on ACADIA Pharmaceuticals (NASDAQ: ACAD  ) .

  I had recommended staying away from the company for now because it looked too risky with a long wait before the company could complete its second phase 3 trial for pimavanserin in patients with Parkinson's disease psychosis.

• [By Sean Williams]

  ACADIA Pharmaceuticals (NASDAQ: ACAD  ) added on 63% since last Friday, following an announcement that the FDA will allow it to file an accelerated new drug application for its Parkinson's disease anti-psychosis drug, Pimavanserin. ACADIA's drug met the primary endpoint of demonstrating highly significant anti-psychotic activity and the secondary endpoint of increased motoric tolerability in its late-stage trial, which provided more than enough evidence for the FDA to give the company the go-ahead to skip another confirmatory trial. Pimavanserin's chances for approval definitely got a boost, but ACADIA's valuation certainly is giving me cause for concern.

• [By Keith Speights]

  One and done
  No more tests required. That's the word from the Food and Drug Administration to Acadia Pharmaceuticals (NASDAQ: ACAD  ) this week. Acadia's shares skyrocketed more than 60% on the news.

Hot Long Term Companies To Buy For 2015: American Heritage International Inc (AHII)

American Heritage International Inc., formerly Cumberland Hills Ltd., incorporated on January 19, 2010, intends to focus on electronic cigarette. The Company�� product includes American Heritage, American One, American Freedom, American Nights, American Standard and Smoking Alternative Gums and Mints.

The Company�� initial and primary line will be the American Heritage line. American One is a disposable Electronic Cigarette, good for over 500 draws, about the equivalent of over two packs of traditional cigarettes. American Freedom will be the brand name for its Nicotine-Free line of Electronic Cigarettes. American Nights will be a product line targeted to the young adult market of social smokers. Smoking Alternative products will include gums, and mints.

Advisors' Opinion:

• [By John Udovich]

  Last week, I talked about small cap electronic cigarette stocks Vapor Corp (OTCMKTS: VPCO) and Hop-On Inc (OTCMKTS: HPNN) as being among the last of the e-Cig�stocks not controlled by ��ig Tobacco,��but Victory Electronic Cigarettes Corp (OTCMKTS: ECIG), mCig Inc (OTCBB: MCIG) and American Heritage International (OTCBB: AHII)�are also�positioning themselves or their technology to exploit opportunities in the e-Cig market or even in�marijuana or cannabis. Last year, industry experts were already saying that�US retail sales of e-cigarettes could reach $1 billion for the year�for roughly�1% of the country's cigarette market. That number might appear small, but its more than double 2012 sales�as sales increasingly�move off the Internet and into more mainstream retailers thanks to their positioning as a���ealthier��alternative to smoking.

• [By James E. Brumley]

  The winds of change are blowing in the cigarette arena, and though in a superficial sense it looks like the usual big tobacco names such as Reynolds American, Inc. (NYSE:RAI) or Lorillard Inc. (NYSE:LO) are positioning to retain their dominance in the new era of cigarette smoking, in reality, it's a little name like American Heritage International Inc. (OTCBB:AHII) that could end up beating the big guys at their own game.

• [By Bryan Murphy]

  Lorillard Inc. (NYSE:LO), Altria Group Inc. (NYSE:MO), and the rest of the big tobacco names may want to take notice. For that matter, anyone with a presence in the electronic cigarette market (which still includes the aforementioned Altria and Lorillard, but many other small payers too) may want to pay attention as well.... e-cig newcomer American Heritage International Inc. (OTCBB:AHII) has just added two states to the number where its premium product can be purchased. The young company promised it was going to expand after jumping into the game on a small scale in - and this isn't a misprint - January of this year. With today's addition of Nevada and Illinois, AHII is now giving MO and LO a run for their money in eleven states. Thirty-nine more to go.

Hot Long Term Companies To Buy For 2015: Bruker Corporation(BRKR)

Bruker Corporation designs, manufactures, services, and sells proprietary life science and materials research systems worldwide. The company?s Scientific Instruments segment offers advanced instrumentation and automated solutions based on magnetic resonance, mass spectrometry, gas chromatography, X-ray, spark-optical emission spectroscopy, atomic force microscopy, stylus and optical metrology, and infrared and Raman molecular spectroscopy technologies. This segment serves pharmaceutical, biotechnology, and molecular diagnostic companies; academic institutions, medical schools, and other non-profit organizations; clinical microbiology laboratories; government departments and agencies; nanotechnology, semiconductor, chemical, cement, metals, and petroleum companies; and food, beverage, and agricultural analysis companies and laboratories. Its Energy & Supercon Technologies segment provides superconducting materials, including metallic low temperature superconductors for use in magnetic resonance imaging, nuclear magnetic resonance, fusion energy research, and other applications; and ceramic high temperature superconductors primarily for fusion energy research applications, as well as non-superconducting Cuponal materials and wires based on co-extruded copper and aluminum, and non-superconducting high technology tools. Its customers include companies in the medical industry; private and public research and development laboratories in the fields of fundamental and applied sciences, and energy research; academic institutions; and government agencies. This segment is also involved in the development of superconductors and superconducting-enabled devices for applications in power and energy, as well as industrial processing industries. The company markets its products through direct sales force; and distributors, independent sales representatives, and other representatives. Bruker Corporation was founded in 1991 and is headquartered in Billerica, M assachusetts.

Advisors' Opinion:

• [By Charley Blaine]

  Scientific-instrument maker Bruker (NASDAQ: BRKR) was down, falling 6.18 percent to $19.19 on Q3 results.

  Commodities
  In commodity news, oil traded down 1.84 percent to $94.61. It was crude's lowest settlement since June 21. Crude had been up as much as 20.4 percent for the year; that's been trimmed to 3.4 percent. Gold settled down 0.8 percent to $1,313.20.

• [By Jake L'Ecuyer]

  Bruker (NASDAQ: BRKR) was down, falling 8.85 percent to $18.65 on Q3 results.

  Commodities
  In commodity news, oil traded down 0.93 percent to $95.48, while gold traded down 0.62 percent to $1,315.50.

Hot Long Term Companies To Buy For 2015: Navios Maritime Partners LP (NMM)

Navios Maritime Partners L.P. (Navios Partners) is an international owner and operator of dry cargo vessels formed by Navios Holdings. Navios GP L.L.C. (the General Partner), a wholly owned subsidiary of Navios Maritime Holdings Inc. (Navios Holdings) acts as the general partner of Navios Partners and received a 2% general partner interest in Navios Partners. Navios Partners is engaged in the seaborne transportation services of a range of drybulk commodities, including iron ore, coal, grain and fertilizer, chartering its vessels under medium to long-term charters. On May 19, 2011, Navios Partners acquired from Navios Holdings the Navios Orbiter, a 76,602 deadweight Panamax vessel. On May 19, 2011, Navios Partners acquired from Navios Holdings the Navios Luz. In June 2012, the Company purchased the Navios Buena Ventura, a 2010 South-Korean-built Capesize vessel of 179,259 dwt from Navios Maritime Holdings Inc.

The Company is an international owner and operator of drybulk carriers formed by Navios Maritime Holdings Inc., a vertically integrated seaborne shipping company. Its vessels are chartered-out under medium to long-term time charters with an average remaining term of approximately four years to a group of counterparties, consisting of Cosco Bulk Carrier Co. Ltd., Mitsui O.S.K. Lines Ltd., Samsun Logix, STX Panocean, Sanko Steamship Co. Ltd., Daiichi Chuo Kisen Kaisha, Augustea Imprese Maritime, Rio Tinto, Constellation Energy Group and Mansel.

As of December 31, 2011, the Company�� fleet consisted of 11 Panamax vessels, six Capesize vessels and one Ultra-Handymax vessel. Its fleet of dry cargo vessels has an average age of approximately 5.6 years. Panamax vessels are flexible vessels capable of carrying a range of drybulk commodities, including iron ore, coal, grain and fertilizer. All of its vessels operate under medium to long-term time charters of three or more years at inception with counterparties. It also operates vessels in the spot market until the vessels have! been fixed under appropriate medium to long-term charters.

The Company competes with China Ocean Shipping, China Shipping Group, Mitsui O.S.K. Lines, Kawasaki Kisen, Nippon Yusen Kaisha, Cargill, Pacific Basin Shipping, Bocimar, Zodiac Maritime, Louis Dreyfus/Cetragpa, Cobelfret and Torvald Klaveness.

Advisors' Opinion:

• [By Igor Greenwald]

  Our Aggressive Portfolio already includes one beneficiary of these trends��avios Maritime Partners (NMM), a partnership with 25 dry bulk carriers, and now, five newly-acquired container ships.

• [By Robert Rapier]

  The index includes everything from behemoths like Enterprise Product Partners (NYSE: EPD) and Kinder Morgan Energy Partners (NYSE: KMP) down to a pair with market capitalizations under $1 billion in Martin Midstream Partners (NASDAQ: MMLP) and Navios Maritime Partners (NYSE: NMM). The total market cap of the index is $328 billion, and its one-, three- and five-year total returns are 20 percent, 48 percent and 194 percent. The index yield is 6 percent.

• [By Eric Volkman]

  As far as unitholder payouts are concerned, the seas for Navios Maritime Partners (NYSE: NMM  ) are calm and smooth. The company has declared its latest quarterly distribution, which is to be $0.4425 per unit paid on Aug. 13 to holders of record as of Aug. 8. That amount matches each of Navios' previous four disbursements, the most recent of which was paid in mid-May. Previous to that, the company handed out a quarter-cent less, at $0.44 per share.